2Geisler J,King N,Dowserr M,et al. Influenceofanastrozole (arimidex),a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in post-menopausal women with breast cancer. Br J Cancer, 1996,74:1286-1291.
3Buzdar A,Jonat W, Howell A,et al. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase Ⅲ trials. J ClinOncol, 1996,7(14):2000-2011.
1[1]Gengli,Duan, Jianying Liang, et al. Rapid Determination of Anastrozole in Plasma by Gas Chromatography With Electron Capture Detection and its Application to an Oral Pharmacokinetic Study in Healthy Volunteers [J]. Biomed Chromatogr,2002 ,16(6) :400～403.
2[2]Geisler J, Berntsen H, Lonning PE. A Novel HPLC-RIA Method for the Simultaneous Detection of Estrone, Estradiol and Estrone Sulphate Levels in Breast Cancer Tissue [J]. J Steroid Biochem Mol Biol,2000 , 72(5):259～264.
3[3]Bock MJ, Bara I, Ledonne N, et al. Validated Assay for the Quantification of Anastrozole in Human Plasma by Capillary Gas Chromatography-63Ni Electron Capture Detection[J]. J Chromatogr B Biomed Sci Appl, 1997 ,700(1～2):131～138.
4Wiseman LR,Adkins JC. Anastrozole,a review of its use in the management of postmenopausal women with advanced breast cancer.Drugs Aging, 1998,13 (4) :321
5Buzdar A ,Jonat W, Howell A, et al. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer:results of overview and analysis of two phase Ⅲ clinical trials. J Clin Oncol, 1996,14 (7) :2000
6Beck MJH, Bara I, LeDonne N, et al. Validated assay for the quantification of anastrozole in human plasma by capillary gas chromatography - ^63 Ni electron capture detection. J Chromatogr B, 1997,700 ( 1-2) :131
7Higa GM, Alkhouri N. Anastrozole: a selective aromatase inhibitor for the treatment of breast cancer. Am J Health - System Pharmacy,1998,55 (5) :445
8Dukes M. The relevance of preclinical models to the treatment of postmenopausal breast cancer. Oncology, 1997,54 ( suppl 2 ) :6
2Wiscman LR, Adkins JC. Anastrozole.. A review of its use in the management of postmenopausal women with advancedbreast cancer EJ]. Drug Aging, 1998, 13 (4): 321-332.
3Geisler J, Berntsen H, Lonning PE. A Novel HPLC-RIA Meth] od for the Simultaneous Detection of Estradiol and Estrone Sul] phate Levels in Breast Cancer Tissue [J].J Steroid BiochenJ Mol Biol, 2000, 72 (5): 259 264. /.
4Bock MJ, Bara I, Ledonne N, et al. Validated Assay for the Quantification of Anastrozole in Human Plasma by Capillary Gas Chromatography 63Ni Electron Capture Detection [J].J Chromatogr B Biomed Sci Appl, 1997, 700 (1-2) : 131-138.
5Gustavo D Mendes, Daniele Hamamoto, Jaime Ilha, et al. Anastrozole quantification in human plasma by high-perform ance liquid chromatography coupled to photospray tandem mass spectrometry applied to Journal of Chromatography B, pharmacokinetic studies [J] 2007, 850 (1-2), 553 559.
6YUAN J, WANG PQ, GE SR. Pharmacokineties of anastrozole in Chinese male volunteers[J]. Acta Phamacol Sin, 2001, 22(6): 573-576.
